상단으로
- Seegene to provide advanced molecular diagnostic technologies and know-how to a Joint Venture in Mexico
- Diversifying business to non-human in vitro diagnostic (IVD) markets such as those in agricultural, livestock, marine quarantine and food safety testing industries
?
SEOUL, South Korea, April 29, 2016 /PRNewswire/ -- Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies headquartered in South Korea, today announced that they have established a Joint Venture ("JV") with a renowned business partner in Mexico, Biodist Group. Partnering with Biodist Group, Seegene will accelerate the adoption of innovative molecular diagnostic (MDx) technologies in the Latin American market that includes Mexico and all the other Central and South American countries.
?
[On left, Seegene Inc. CEO, Dr. Jong-Yoon Chun and on the right, Biodist Group CEO, Rebeca Miramontes Vidal]
?
?
The new company, “Biodist- Seegene Diagnostics”, was established with an ownership stake of 50% for each company. Seegene will license its proprietary MDx technologies and know-hows to Biodist- Seegene Diagnostics. Biodist Group will provide a marketing and sales distribution network.
?
With Seegene’s multiplex technologies that enable simultaneous detection and identification of multiple pathogens or targets in a single test, Biodist-Seegene Diagnostics will create new business opportunities to address the local market needs. Biodist- Seegene Diagnostics aims to develop, manufacture and commercialize localized products in Mexico and to expand its market presence to the fast-growing Latin American markets.
?
In addition to its current business in human IVD, Seegene is seeking to expand the applicability of its technologies into the non-human IVD markets such as those in the agricultural, marine products quarantine and food safety testing industries.
?
Molecular diagnostic methods, despite their accuracy compared to other conventional methods, have limitedly been used in the human IVD field due to their high costs. Seegene’s technologies, by greatly reducing the test cost through simultaneous detection of multiple pathogens or targets in a single test, will open up new business opportunities in the non-human IVD market space.
?
About Seegene
Seegene is the world’s leading developer of multiplex molecular technologies and multiplex clinical molecular diagnostics (M-MoDx). Seegene’s core enabling technologies, ACP™, DPO™, READ™, TOCE™ and MuDT™,are the foundation for M-MoDx tests that can simultaneously detect multiple targets with high sensitivity, specificity and reproducibility. Seegene’s products simultaneously detect multiple pathogens or targets with great reliability and throughput, ultimately providing the most efficient basis for saving time, labor and cost. Seegene’s mission is to maintain leadership in molecular diagnostics for infectious diseases, genetics, pharmacogenetics and oncology using innovative proprietary technologies.
Seegene is the world’s leading developer of multiplex molecular technologies and multiplex clinical molecular diagnostics (M-MoDx). Seegene’s core enabling technologies, ACP™, DPO™, READ™, TOCE™ and MuDT™,are the foundation for M-MoDx tests that can simultaneously detect multiple targets with high sensitivity, specificity and reproducibility. Seegene’s products simultaneously detect multiple pathogens or targets with great reliability and throughput, ultimately providing the most efficient basis for saving time, labor and cost. Seegene’s mission is to maintain leadership in molecular diagnostics for infectious diseases, genetics, pharmacogenetics and oncology using innovative proprietary technologies.
?
For further information, visit www.seegene.com or contact Seegene Investor Relations
Yoon Chung (yjchung7@seegene.com, Tel: 82-2-2240-4082)
Alex Baek (mwbaek@seegene.com, Tel: 82-2-2240-4025)
Yoon Chung (yjchung7@seegene.com, Tel: 82-2-2240-4082)
Alex Baek (mwbaek@seegene.com, Tel: 82-2-2240-4025)
?
?
?
Related
?
-
Jun. 08
2016
-
Mar. 07
2016
Datenschutz-Präferenz-Center
Unbedingt erforderliche Cookies
Immer aktiv
Diese Cookies sind zur Funktion der Website erforderlich und können in Ihren Systemen nicht deaktiviert werden. In der Regel werden diese Cookies nur als Reaktion auf von Ihnen getätigte Aktionen gesetzt, die einer Dienstanforderung entsprechen, wie etwa dem Festlegen Ihrer Datenschutzeinstellungen, dem Anmelden oder dem Ausfüllen von Formularen. Sie können Ihren Browser so einstellen, dass diese Cookies blockiert oder Sie über diese Cookies benachrichtigt werden. Einige Bereiche der Website funktionieren dann aber nicht.
Funktionale Cookies
Diese Cookies ermöglichen die Bereitstellung erweiterter Funktionalitäten und dienen der Personalisierung. Die Cookies werden insbesondere als Reaktion auf Ihre Aktionen gesetzt und hängen von Ihren konkreten Serviceanfragen (z. B. Einstellung der Sprache) ab.
Analyse- und Marketing Cookies
Wir setzen darüber hinaus auch Analyse- und Marketing-Cookies ein. Dabei handelt es sich um Cookies, die technisch nicht erforderlich sind. Wir setzen diese ein, um Ihr Verhalten auf unserer Website zu verstehen und unser Angebot zu verbessern.